We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Immunotherapy is Targeted to Alterations in Tumor Suppressor Gene

News   Mar 02, 2021 | Original story from Johns Hopkins Medicine

 
Immunotherapy is Targeted to Alterations in Tumor Suppressor Gene

This image shows mitochondrial staining (green) and nuclear staining (blue) of human epithelial cells engineered to express oncogenic Ras. Credit: David Kashatus/ National Cancer Institute, Univ. of Virginia Cancer Center

 
 
Advertisement
 

RELATED ARTICLES

CRISPRoff: A New Addition to the CRISPR Toolbox

News

Researchers have described a new gene-editing technology called CRISPRoff that allows researchers to control gene expression with high specificity while leaving the sequence of the DNA unchanged. The method is stable enough to be inherited through hundreds of cell divisions, and is also fully reversible.

READ MORE

IL-33 Implicated in SARS-CoV-2 Immunity

News

Researchers have unveiled a novel feature of COVID-19 immunity, which could have implications for future therapies. The study points to the involvement of Interleukin 33 when immune cells encounter Sars-CoV-2 for a second time.

READ MORE

Exploring Functional Neurological Disorder and Vaccines

News

Videos of people experiencing severe neurological symptoms, including convulsions and difficulty walking, purportedly after receiving a COVID-19 vaccine, have surfaced on social media channels. The millions of people watching these videos might conclude that the vaccine is either quite dangerous to produce such symptoms or that the people in the videos are faking their symptoms. Both conclusions are incorrect, according to neurologist and psychiatrist David Perez.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE